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Intercellular cell adhesion molecule-1 (ICAM-1) is an inducible cell surface glycoprotein that is expressed
on many cell types. Inﬂuenza virus infection enhanced ICAM-1 expression and messenger RNA levels.
Human bronchial epithelial cells (HBEpC) and nasal epithelial cells, on exposure to different strains of
inﬂuenza virus (H1N1, H3N2, and H9N1) showed signiﬁcant increase in ICAM-1 gene expression
(po0.001) along with the ICAM-1 protein levels (surface and secreted). Depleting ICAM-1 in HBEpC with
ICAM-1 siRNA and subsequently infecting with H1N1 showed increased viral copy numbers. Inﬂuenza
virus infection in HBEpC resulted in up-regulation of NF-ĸB protein and the lack of ICAM-1 decreased NF-
ĸB activity in NF-ĸB luciferase reporter assay. Addition of exogenous IL-1β to HBEpC induced the ICAM-1
expression and decreased matrix gene copy number. Taken together, HBEpC induced ICAM-1 plays a key
role in modulating the inﬂuenza virus survival possibly through the NF-ĸB pathway.
Published by Elsevier Inc.Introduction
Inﬂuenza A virus is a negative-strand RNA virus that is among
the most common pathogens and poses a continuous threat to
human health (Stohr, 2002). Inﬂuenza A viruses causing acute
infections, continuously escape from recognition by virus neu-
tralizing antibody as a result of antigenic drift or shift (Doherty
et al., 2006). Even though predicting the severity of continuously
emerging human inﬂuenza virus strains remains a high priority, it
is limited by our incomplete understanding of the molecular
determinants of pathogenicity in inﬂuenza infections. Although
there are several factors that determine the severity of viral
infection, interaction between inherent viral properties and host
cellular response ultimately determines disease outcome. A major
site of viral contact with the host, and main target of infection and
inﬂammation, is the airway epithelium (Kagnoff and Eckmann,
1997). Epithelial cells in the airways have a variety of inﬂamma-
tory and immune defense mechanisms to respond to virus infec-
tion that include the expression of cytokines, MHC class II (Gao
et al., 1999) pro-inﬂammatory molecules, intercellular adhesion
molecule-1 (ICAM-1) (Papi and Johnston, 1999a, b), IFN regulatory
factor-1 (Uetani et al., 2008), and nitric oxide synthase (Uetani
et al., 2000).gy Branch, National Institute
Road, MS 4020, Morgantown,ICAM-1 (CD54) belongs to the immunoglobulin superfamily of
adhesion molecules, is expressed at low levels in diverse cell types,
and is induced by cytokines (TNF-α, interleukin-1) and bacterial
lipopolysaccharide (Dustin et al., 1986, 1988). It was originally
believed that ICAM-1 played a purely adhesive role, but recent
evidence suggests that ICAM-1 can transduce biochemical signals
(Matsukura et al., 1996; Matsunaga et al., 1996). In rhinovirus
induction of ICAM-1, promoter activity was critically found to be
dependent upon up-regulation of NF-ĸB proteins (Papi and John-
ston, 1999b). Though the role of ICAM-1 in rhinovirus has been well
studied as the major receptor (Greve et al., 1989; Othumpangat
et al., 2012), little has been reported with inﬂuenza virus. Here we
demonstrate that inﬂuenza infection results in up-regulation of
ICAM-1 and the nuclear factor-ĸB (NF-ĸB) complex which regulates
inﬂuenza virus replication in airway epithelial cells.
The NF-ĸB family of proteins was initially characterized as a
group of transcription factors critical to the immune response to
pathogens and other foreign bodies. Subsequently, these proteins
have been found to regulate expression of a variety of genes
responsible for diverse biological processes, including cell pro-
liferation, migration, survival, and stress response. In the basal
state, NF-ĸB remains in the cytoplasm by interacting with IĸB, an
inhibitory protein. IĸB phosphorylation, ubiquitination, and sub-
sequent proteasomal degradation leads to the release of NF-ĸB
(DiDonato et al., 1997), which then enters the nucleus and acti-
vates the expression of pro-inﬂammatory genes. Thus, diverse
upstream signaling pathways converge at the IκB kinase (IKK)
complex, which phosphorylates IκB that leads to NF-ĸB activation.
Fig. 1. Inﬂuenza virus alters the cell adhesion and extracellular molecules. PCR
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prevent virus- and/or double-stranded RNA (dsRNA)-mediated
activation of the NF-ĸB pathway and depends on the ability of NS1
protein of inﬂuenza A virus to bind to dsRNA. NS1-mediated
inhibition of the NF-ĸB pathway may thus play a key role in the
pathogenesis of inﬂuenza A virus (Wang et al., 2000). Furthermore,
it was suggested that NF-ĸB differentially regulates viral RNA
synthesis (Kumar et al., 2008). Here we investigated the role of
ICAM-1 modulating the viral copy numbers during the early stages
of infection.
Inﬂuenza virus induced ICAM-1 gene expression and signaling
were investigated in undifferentiated primary human bronchial
epithelial cells (HBEpC). Inﬂuenza virus infection was found to
enhance ICAM-1 expression and induces steady-state messenger
RNA (mRNA) levels. The intracellular signaling pathways leading
to enhanced ICAM-1 expression appeared to involve the activation
of NF-ĸB. Consequently, NF-ĸB activation resulted in the suppres-
sion of inﬂuenza virus propagation.array analyses of HBEPC exposed to inﬂuenza virus and the expression of extra-
cellular matrix cell adhesion molecules ICAM-1, NCAM-1 (Neural cell adhesion
molecule-1), PECAM-1 (Platelet/endothelial cell adhesion molecule-1), and
VECAM-1 (Vascular cell adhesion molecule-1). HBEpC were infected with inﬂuenza
viruses, H1N1, H3N2, and H9N1 with an MOI of 1.0 for 3 h. Total RNA was isolated
and subjected to the human extracellular matrix and adhesion molecules RT2
Proﬁler™ PCR array (Qiagen). The data are representative of 3 independent
experiments (N¼3). Data are presented as the means 7SE, ***po0.001, **po0.01
compared with mock controls.Results
Inﬂuenza virus alters the expression of extracellular matrix
and adhesion molecules
The major site of viral contact with the host and the target of
infection and inﬂammation is the airway epithelium. Airway epi-
thelial cells respond to virus by expressing a variety of inﬂam-
matory and immune defense proteins that protect the cells against
the virus. In order to understand the immediate response on the
cell surface, we infected HBEpC with 3 different strains of inﬂu-
enza virus, H1N1, H3N2 and H9N1, and analyzed extracellular
matrix and adhesion proteins using a RT2 proﬁler PCR array for
extracellular matrix and adhesion molecules (Fig. 1). Data showed
signiﬁcant differential expression of several genes including the
cell adhesion molecules ICAM-1 (5–7.5 fold) and PECAM-1 (0.6–2
fold) (Fig. 1). Expression of ICAM-1 was highest in cells infected
with H3N2 and H9N1 (7.5–8 fold) compared to H1N1 (5.0 fold)
strains. The microarray contained a panel of 86 genes for extra-
cellular matrix and adhesion molecules and a signiﬁcant increase
in the expression of metalloproteases (MMPs), protease inhibitors,
and integrins were also observed (data not shown). Although there
was a signiﬁcant increase in PECAM-1 in H3N2 and H9N1 strains,
it was not comparable to the levels of ICAM-1. ICAM-1 was more
consistent across different strains of inﬂuenza virus than PECAM-1.
Here, we explored the role of ICAM-1 in regulating the survival
and replication of inﬂuenza virus in host cells was further studied.
Inﬂuenza virus induced ICAM-1 expression in primary human
bronchial epithelial cells
The induction of ICAM-1 in HBEpCs exposed to Inﬂuenza virus
was dependent upon the strains of inﬂuenza virus used. Expres-
sion of ICAM-1 in inﬂuenza infected cells peaked at 3 h and
showed a 7–12 fold increase over mock-infected cells at 6 h of
exposure (Fig. 2A). The PCR array data was reproducible with the
highest expression of ICAM1 in H9N1 infected cells after 3 h of
exposure (12 fold). Based on the PCR data, the 3 h time point was
chosen for all subsequent studies. Interestingly, the H3N2 strain
showed an inverse relationship to the expression of ICAM-1 and
the inﬂuenza virus copy number (Fig. 2B). A reduction in ICAM-1
expression at 6 h and an increase in virus matrix copy numbers
was observed with H1N1 and H3N2 strains. The heat inactivated
virus failed to induce the expression of ICAM-1 (Fig. 2C) in HBEpC.
The expression of soluble ICAM-1 (sICAM-1) protein released
into the culture medium was estimated by ELISA. Data presentedin Fig. 3 shows that the expression of sICAM-1 was signiﬁcantly
higher in cells infected with H1N1 (22 ng/mL, po0.01), H3N2
infected strains (20 ng/mL, po0.05), and H9N1 (24.5 ng/mL,
po0.05) compared to the mock infected cells (15 ng/mL). ICAM-1
surface expression was monitored by ﬂow cytometry and showed
an increase in ICAM-1 protein expression compared to the mock
infected cells (Fig. 3B). H9N1 infected cells showed the highest
increase in ICAM-1 surface expression compared to the other two
strains of inﬂuenza virus. We further examined the expression of
ICAM-1 in cells exposed to different strains of inﬂuenza virus and
heat inactivated virus to show the active virus with the multi-
plication only could induce the expression of ICAM-1. Western blot
analysis shown in Fig. 3C shows that the ICAM-1 increased on
exposure to active virus compared to heat inactivated virus.
The surface expression of ICAM-1 was further conﬁrmed by
confocal microscopy using HBEpCs exposed to H3N2 and H1N1
strains (3 h, MOI¼1.0) (Fig. 4). An intense green ﬂuorescence in
cells infected with the virus (lower panels) clearly demonstrates
the increased expression of ICAM-1 compared to the mock infec-
ted cells (upper most panel). The cell integrity in H1N1 (bottom
panel) or H3N2 (middle panel) infected cells was examined with
phalloidin stain (red) showing disruption in actin ﬁlaments in
inﬂuenza infected cells.
Next we analyzed whether cell type plays a role in inﬂuenza
induced ICAM-1 expression. Primary human nasal epithelial cells
were exposed for 3 h to inﬂuenza A (H1N1, H3N2, or H9N1) at an
MOI of 1.0. Nasal epithelial cells upregulated ICAM-1 expression
2.5 fold with H1N1, and 4 fold by H3N2 and H9N1 strains (Fig. 5A).
We also evaluated the inﬂuenza virus matrix gene copy numbers
to conﬁrm the infection efﬁciency (Fig. 5B). Infection with H3N2
showed the lowest levels of matrix gene copy number as com-
pared to the H1N1 or H9N1 strains and that was comparable to the
results obtained with HBEpC. The difference in expression with
different cells (nasal vs bronchial) could be due to their physio-
logical difference, although we have not assayed for the nature of
sialic acid receptors (2, 3 or 2, 6) in either cell type.
Fig. 2. Inﬂuenza virus induced up-regulation of ICAM-1 mRNA. Conﬂuent HBEpC monolayers were infected with different strains of inﬂuenza virus (H1N1, H3N2, and H9N1)
for 6 h with an MOI of 1.0, and samples were analyzed at 3 h and 6 h postinfection. (A) ICAM-1 expression in response to H1N1, H3N2 and H9N1. Expression of ICAM-1 was
analyzed by RT-PCR. (B) Inﬂuenza virus matrix gene copy number was analyzed from the RNA extracted from HBEpC infected with inﬂuenza virus. (C) ICAM-1 expression in
response to heat inactivated H1N1, H3N2 and H9N1. Virus were heat inactivated at 56 °C for 30 min and HBEPC exposed to the virus for 3 h. The expression of ICAM-1 was
analyzed by RT-PCR. The data are representative of 3 to 4 independent experiments. Data shown as mean7SE (n¼4 experiments for RNA isolation and n¼3 experiments for
plaque assay). The different letters (a or b) represents the signiﬁcant difference within groups (3 h and 6 h), and the letter ‘a’ shows the signiﬁcant difference compared to the
control. ***po0.001, **po0.01 compared with mock.
S. Othumpangat et al. / Virology 487 (2016) 85–94 87Silencing ICAM-1 changes the viral copy numbers
To investigate the role of ICAM-1 in regulating the inﬂuenza
infection efﬁciencies in bronchial epithelial cells, epithelial cells
were transfected with SCR siRNA or ICAM-1 siRNA and infected
with H1N1 strain. As shown in Fig. 6A, ICAM-1 knock-down by
siRNA was efﬁcient (70–80%) and highly signiﬁcant (po0.001) in
both uninfected and infected cells compared to the scrambled
siRNA transfected cells. Interestingly, the lower expression of
ICAM-1 in siRNA ICAM-1 transfected cells showed higher matrix
copy numbers (Fig. 6B). There was signiﬁcantly lower (po0.001)
extracellular secretion of ICAM-1 in cells that were transfected
with siRNA ICAM-1 (4.5 ng/mL) compared to the uninfected siRNA
SCR (15.2 ng/mL) (Fig. 6C). Upon infection the sICAM-1 levels were
signiﬁcantly increased in SCR siRNA (22.0 ng/mL) compared to
siRNA ICAM-1 transfected and infected cells (7.1 ng/mL). Western
blot analysis showed a lower expression of ICAM-1 as well as NF-
ĸBp65 in cells that were treated with siRNA ICAM-1 (Fig. 6D). We
further conﬁrmed this in a separate experiment by using a speciﬁc
ICAM-1 blocking antibody to prevent ICAM-1 from binding to its
receptors and to abrogate the ICAM-1 expression. The results
showed (Fig. 7) signiﬁcant up-regulation of the matrix copy
numbers in cells treated with the ICAM-1 antibody (po0.001)
compared with control cells treated with the IgG isotype antibody.
The inhibitory effect of the antibody on viral replication was less
potent than the effect of gene silencing by siRNA studies. Similarly,
the inhibitor treatment to reduce ICAM-1 expression was alsohighly effective compared to the antibody treatment. We used
different concentrations (0–100 ng/mL) of the ICAM-1 inhibitor A
205804 (TOCRIS), whereas 50 ng/mL showed the highest (100%)
increase in matrix copy number compared to the DMSO treated
control cells infected with inﬂuenza virus (Fig. 7).
Effects of IL-1β on inﬂuenza virus infection
In another set of experiments, we added exogenous recombinant
human IL-1β to induce ICAM-1 expression (Terajima et al., 1997;
Tosi et al., 1992). Different concentrations of exogenous IL-1β (R&D
systems, MN) (50 and 100 ng/mL) were added to conﬂuent layers of
HBEpCs and incubated for 2 h. RNA was extracted and the expres-
sion of ICAM-1 analyzed. 50 ng/mL of IL-1β signiﬁcantly induced
ICAM-1 transcripts by 12 fold while 100 ng/mL of IL-1β showed 13
fold increase (po0.001). Concordant increase in NF-ĸBp65 was also
observed with both concentrations of IL-1β. Following treatment
with IL-1β, cells were exposed to H1N1 strain for another 3 h at an
MOI of 1.0. When normalized to control (treated as 1), the ICAM1
levels (Fig. 8 B) were increased 6.2 and 10 fold with IL-1β 50 and
100 ng/mL, respectively. Interestingly, the level of NF-ĸB was also
increased in both treatments and was higher in cells treated with
100 ng/mL of IL-1β. Western blot analysis showed increased
expression of ICAM-1 and NF-ĸBp65 proteins with increasing con-
centrations of IL-1β (Fig. 8C). Fig. 8D shows IL-1β (po0.001)
treatment caused a signiﬁcant reduction in inﬂuenza A virus matrix
gene copy number. To further evaluate the role of ICAM-1, we
Fig. 3. Inﬂuenza virus induced secretion of soluble ICAM-1 protein. (A) HBEpC were exposed to MOI of 1.0 H1N1, H3N2, or H9N1 inﬂuenza virus or control cells mock
infected for 3 h. Culture supernatant was collected and subjected to ELISA speciﬁc for sICAM-1 and quantiﬁed using a standard curve. (B) ICAM-1 cell surface protein
expression was measured by ﬂow cytometry after staining HBEpCs infected with MOI of 1.0 H1N1, H3N2, and H9N1 for 3 h, and uninfected control cells, with ICAM-1
primary antibody and Alexa 555 secondary antibody. (C) Western blot showing the increased expression of ICAM-1 protein in cells infected with active inﬂuenza virus
compared to the heat inactivated virus strains. Data shown as mean7SEM for experiments performed in triplicate (**po0.01, *po0.05) compared to the mock. (N¼3).
S. Othumpangat et al. / Virology 487 (2016) 85–9488inhibited the ICAM-1 levels with ICAM-1 chemical inhibitor 205804,
and then exposed to 50 and 100 ng/mL of IL-1β. Fig. 8E shows that
the treatment with IL-1β did not alter the copy numbers due to the
inhibition of ICAM-1 by the speciﬁc inhibitor.
ICAM-1 regulation during inﬂuenza virus infection is mediated
through NF-ĸB activation
A NF-ĸB responsive luciferase construct was used (Fig. 9) to
examine the ICAM-1 mediated NF-ĸB response in HBEpC. Cells
transfected with siRNA speciﬁc for ICAM-1, co-transfected with the
NF-ĸB reporter showed a signiﬁcant reduction in luciferase activity
compared to the SCR siRNA transfected cells (Fig. 9A). The lack of
ICAM-1 in cells transfected with ICAM-1 siRNA reduced the acti-
vation of NF-ĸB, On the other hand, infection with inﬂuenza virus
induced the luciferase activity in SCR siRNA treated cells but
showed a partial reduction in luminescence in cells treated with
ICAM siRNA (Fig. 9B). These data suggests that a reduction in
ICAM-1 levels signiﬁcantly reduces the NF-ĸB activity.Discussion
This study provides further evidence that the cellular adhesion
molecule ICAM-1 has a signiﬁcant role in regulating inﬂuenza
replication and/or survival during the early stages of infection. Our
data suggests that up-regulation of ICAM-1 induces expression of
NF-ĸB protein which further modulates viral replication in the cells
in early stages of infection. The primary site of viral contact with the
host and the primary target of infection are the airway epithelial
cells (Kagnoff and Eckmann, 1997). Among cell lines derived from
the human respiratory tract, bronchial and nasal epithelial cellsshowed signiﬁcant up-regulation of ICAM-1 upon exposure to
inﬂuenza virus. Increase in ICAM-1 levels on exposure to inﬂuenza
virus has been reported in NCI-H292 cells (Matsukura et al., 1996).
Airway epithelial cells responded to the viral invaders by expressing
a variety of inﬂammatory and immune defense proteins that defend
the cells against the viral infection (Medzhitov and Janeway, 2000).
Also, tissue tropism plays a key role in viral infection and induction
of inﬂammatory responses (Meliopoulos et al., 2014). The bronchial
cells showed a higher fold increase in ICAM-1 expression compared
to nasal epithelial cells. Epithelial cells have the inﬂuenza binding
receptors (2, 3 sialic acid) on their surfaces, but the difference in
expression probably is due to the cell physiology as described in a
study looking at the infectivity of inﬂuenza virus and the differential
response to tissues tropism (Zeng et al., 2013). Our data also sug-
gests that different cell types of the respiratory tract respond dif-
ferently to inﬂuenza virus infection.
Inﬂuenza virus induced NF-ĸB activity, while the reduction in
ICAM-1 substantially decreased NF-ĸB reporter plasmid mediated
luciferase activity. If ICAM-1 did not initiate NF-ĸB activation upon
viral entry into bronchial cells, then ICAM-1 inhibition would not
affect the NF-ĸB activity and virus replication. Our hypothesis may
have important translational implications, as the pharmacological
activation of NF-ĸB, using strategies based on addition of cytokines
like IL-1β, could favor an induction of ICAM-1 that alter the phos-
phorylation and activation of the NF-ĸB pathway, resulting in
decreased inﬂuenza matrix gene copy number. This notion may
offer a promising new approach for the management of inﬂuenza
virus infection. More importantly, the correlation observed between
the patterns of viral replication and ICAM-1 expression of the host
cells, together with the evidence that ICAM-1 is able to regulate the
NF-ĸB pathway, provides a plausible molecular mechanism to
explain both tropism and clinical manifestations of infection.
Fig. 4. Induction of ICAM-1 expression by inﬂuenza virus in HBEpC as detected by immunoﬂuorescence. HBEpC were infected with H3N2 and H1N1 at an MOI of 1.0 or mock
infected. After virus adsorption for 45 min at 37 °C, the cells were incubated for 3 h. Thereafter, cells were washed, ﬁxed, and processed for immunoﬂuorescence staining of
ICAM-1. Lane 1 shows the uninfected control cells. Lane 2 showing the Inﬂuenza H3N2 and lane 3 showing H1N1 infected cells. White arrows indicate the difference in
morphology of the cells exposed to virus. Cells were stained with anti-ICAM-1 antibodies (green), actin ﬁlaments stained by phalloidin (red), and the nucleus by DAPI (blue)
observed under the LSM-510 confocal microscope (63X-objective).
Fig. 5. ICAM-1 expression in human primary nasal cells. Nasal epithelial cells were infected with inﬂuenza virus H1N1 (WSN), H3N2, and H9N1 for 3 h. (A) The expression of
ICAM-1 mRNA in nasal epithelial cells infected with H1N1 (WSN), H3N2, and H9N1 at an MOI of 1.0. Fold change was normalized with housekeeping gene GAPDH.
(B) Inﬂuenza virus matrix gene copy number was analyzed from the RNA extracted from nasal cells infected with H1N1, H3N2, and H9N1 strains of inﬂuenza virus. The data
are representative of 3 independent experiments (N¼3). Data are presented as the means7SE, **po0.01, *po0.05 compared with independent mock controls.
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essential role in the regulation of many physiological responses, ran-
ging from immune and inﬂammatory responses to cell differentiationand apoptosis (Ghosh et al., 1998). Using reporter gene assays we were
able to demonstrate that ICAM-1 has a role in NF-ĸB pathway in
HBEpC. If ICAM-1 modulates extracellular signaling through changes
Fig. 6. Increased viral copy numbers in bronchial cells lacking ICAM-1. HBEpC transfected with ICAM-1 speciﬁc siRNA or a scrambled siRNA control for 32–36 h and
subsequently exposed to H1N1 (WSN) for another 3 h. (A) ICAM-1 mRNA expression in cells transfected with siRNA ICAM-1 or SCR siRNA and infected with inﬂuenza virus or
left uninfected. (B) Matrix copy number of inﬂuenza virus in cells infected after transfected with siRNA ICAM-1 or SCR siRNA. (C) sICAM-1 levels in cell supernatants collected
from cells transfected with SCR siRNA or ICAM-1 siRNA and infected with MOI of 1.0 inﬂuenza virus. (D) Western blot showing the reduction in ICAM-1 and NF-kBp65 in cells
transfected with ICAM-1 siRNA and infected with MOI of 1.0 inﬂuenza virus. The data are representative of 3 independent experiments (N¼3). Data are presented as the
means7SE, ***po0.001, **po0.01 compared with SCR siRNA controls.
Fig. 7. ICAM-1 inhibitors induced inﬂuenza matrix gene copy number. HBEpC were
treated with anti-ICAM-1 antibody (0.1 or 1.0 mg/mL) or with a matched isotype
antibody control for 2 h and then infected with inﬂuenza A H1N1 for an additional
3 h. HBEpC were also treated with ICAM-1 inhibitor-A 205804 (10 and 50 ng/mL)
(TOCRIS) or a DMSO control for 2 h and then infected with inﬂuenza A H1N1 for
additional 3 h. Matrix gene copy number was measured by RT-PCR from the RNA
extracted from cells infected with inﬂuenza virus or mock. The data are repre-
sentative of 3 independent experiments (N¼3). Data are presented as the mean-
s7SE, ***po0.001, **po0.01, *po0.05 compared with IgG controls or DMSO-
controls.
S. Othumpangat et al. / Virology 487 (2016) 85–9490in the expression of ligands and/or receptors, then these changes
might affect the NF-ĸB signal cascades. In a study with rhinovirus,
ICAM-1 promoter activity was found to involve up-regulation of NF-ĸB
proteins (Papi and Johnston, 1999a, b). Similarly, in our studies on
exposure to inﬂuenza virus the NF-ĸBp65 subunits were induced withthe increased expression of ICAM-1. The cell surface expression of
ICAM-1 protein was also increased in cells infected with the viruses
(Fig. 3B). Our data suggests that the mechanism involved in inﬂuenza
virus mediated induction of ICAM-1 has a role in NF-ĸB phosphor-
ylation which could be one of the mechanism involved in regulating
the viral replication in airway epithelial cells. Our ﬁndings explain the
importance of ICAM-1, a molecule important in inﬂammatory cell
recruitment and activation in asthma (Wegner et al., 1990). We cannot
fully dismiss that the other NF-kB dependent mechanisms may be
involved in the observed effects, such as expression of the viral NS1
protein counteracting the activation of NF-ĸB (Munir et al., 2011) and
NF-ĸB promoter activity (Wang et al., 2000). Heat inactivated virus
was failed to induce the expression of ICAM-1, suggesting that active
virus are required for the induction of ICAM-1 expression.
Both inﬂuenza virus infection and exogenous IL-1β increased
ICAM-1 expression on epithelial cells. Addition of IL-1β sig-
niﬁcantly reduced airway epithelial cells susceptibility to inﬂuenza
virus infection, possibly through the mechanism of induction of
ICAM-1, which in turn, induced the NF-ĸB pathway. Earlier studies
by Terajima et al. (1997) have also shown that the IL-1β increased
ICAM-1 expression in primary epithelial cells upon exposure to
rhinovirus. Interestingly, when ICAM-1 was inhibited by the che-
mical inhibitor 205804, the cells failed to induce the IL-1β effect,
suggesting that ICAM-1 may have an important role in modulating
inﬂuenza virus replication.
We also studied the effect of ICAM-1 down-regulation in
modulating viral replication in epithelial cells. This was done by
blocking ICAM-1 expression with the ICAM-1 speciﬁc chemical
inhibitor 205804, and the anti-ICAM-1 antibody. As expected,
Fig. 8. Recombinant IL-1β induced ICAM-1 expression in bronchial epithelial cells. (A) IL-1β (50 and 100 ng/mL) was added to conﬂuent layers of HBEpC and after a period of
2 h, RNA extracted and analyzed the expression of ICAM-1 and NF-κB. (B) HBEpC were treated with IL-1β for a period of 2 h, and then infected with H1N1 of an MOI of 1.0 for
3 h. RNA extracted and analyzed the expression of ICAM-1 and NF-κB. (C) Western blot analysis showing the changes in NF-kBp65 and ICAM-1 levels in IL-1β treated and
untreated HBEpC infected with inﬂuenza H1N1 for 3 h. The numbers in parenthesis shows the expression levels NF-κBp65 quantiﬁed and normalized to GAPDH. (D) Matrix
copy number of inﬂuenza virus in cells treated with IL-1β and then infected with H1N1 for 3 h. (E) Blocking ICAM-1 prevented IL-1β mediated reduction in copy number.
HBEpC were treated with ICAM-1 inhibitor-A 205804 (50 ng/mL) (TOCRIS) for 2 h. Subsequently the cells were treated with IL-1β (50 or 100 ng/ mL) for another 2 h followed
by inﬂuenza A H1N1 for 3 h. The data are representative of 3 independent experiments. Data are presented as the means 7SE, ***po0.001, **po0.01 compared with mock
or infected controls without IL-1β.
S. Othumpangat et al. / Virology 487 (2016) 85–94 91reduced levels of ICAM-1 increased inﬂuenza virus infection as
measured by the matrix gene copy numbers, suggesting the role of
the endogenous ICAM-1 in regulating the inﬂuenza virus infection.
Up-regulation of ICAM-1 expression on epithelial cells in response
to inﬂuenza infection may be relevant to the pathogenesis of air-
way inﬂammation associated with mechanisms of viral exacer-
bations of asthma.
In conclusion, our data demonstrate that inﬂuenza infection
up-regulates ICAM-1 and NF-ĸB in airway epithelial cells, and
represses virus propagation and survival. NF-ĸB also exerts apop-
totic and inﬂammatory effects that induce the clearance of infec-
ted cells, becoming unfavorable for inﬂuenza virus survival.
Pharmacological induction of ICAM-1 pathway may have impor-
tant anti-viral effects and could be beneﬁcial in the management
of inﬂuenza infection.Materials and methods
Cell culture
HBEpC that are from humans with no underlying diseases were
purchased from Promo Cell (Hamberg, Germany), and Cell appli-
cations Inc. (San Diego, CA) and sub-cultured as recommended by
the supplier in epithelial cell growth media. Human nasal epi-
thelial cells were purchased from Promo cell and maintained bythe medium and supplements provided by the supplier. All cells
were passaged when 80% conﬂuent. Cells of lower passage (P 2–6)
were used throughout the experiments. Madin–Darby canine
kidney (MDCK) cells were used for the propagation of inﬂuenza
virus. MDCK cells were cultured in EMEM (ATCC) supplemented
with 10% FBS and 100 IU/ml penicillin and 100 mg/ml streptomycin
sulfate.
Viruses and their infections
Inﬂuenza strain A/Aichi/2/68 (H3N2- ATCC 1680) was pur-
chased from the ATCC and maintained as described (Blachere et al.,
2011, 2009). Inﬂuenza virus H1N1 (A/WSN/33) was a kind gift
from Dr. Robert A. Lamb (Northwestern University, IL), and H9N1
strain was a kind gift from Dr. Daniel Perez (University of Georgia,
GA). H3N2 was isolated from human and was deposited with ATCC
by M T Coleman, Centers for Disease Control and Prevention
(Atlanta, USA). H9N1strain is a genetically modiﬁed avian inﬂu-
enza strain of H9N2 by Perez group.
The initial inoculum was added to the cells (1106) to make
a multiplicity of infection (MOI) of 1.0 infection or adjusted
appropriately depending on the number of cells in a six well or 96
well plate. All infections of airway epithelial cells were performed
in 6-well plates at a dose MOI of 1.0 unless otherwise speciﬁed.
Control cells were treated in the same manner as infected cells but
without the addition of virus (mock). Six well plates were seeded
Fig. 9. Lack of ICAM-1 Inhibit NF-ĸB activation on exposure to inﬂuenza virus.
HBEpC were transiently transfected with NF-κB expression vector (100 ng), the NF-
ĸB reporter plasmid pELAM-luc (0.5 mg), or the negative control expression plas-
mid, along with ICAM-1 siRNA or a scrambled siRNA. After 36 h, luciferase levels
were determined. The values indicated represent normalized luciferase activities
relative to the control transfection using the reporter plasmid and an empty
expression vector. (A) HBEpC were transfected with reporter plasmid and siRNA.
(B) After transfection with the NF-kB reporter plasmids and siRNA ICAM-1 and SCR
siRNA were infected with H1N1 MOI of 1.0 for 3 h. Renilla luciferase activity was
measured using a Promega Glomax luminometer, and the data were normalized
with ﬁreﬂy luciferase activity. Data shown as mean7SEM for experiments per-
formed in triplicate. The data are representative of 3 independent experiments
(N¼3). Data are presented as the means7SE, **po0.01, *po0.05 compared with
scrambled siRNA controls.
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were rinsed with PBS, and then virus diluted in modiﬁed Hank's
Balanced Salt Solution (HBSS) was added to each well. Excess
viruses were removed by washing the cells with PBS after 45 min
of incubation at 37 °C. Fresh F-12 media was added containing
1 mg/mL of TPCK-trypsin (Sigma-Aldrich, St. Louis, MO) and incu-
bated at 37 °C and 5% CO2. TPCK was not added to A/WSN/33 virus.
Cells were harvested at different time intervals and used for pro-
tein and RNA studies.
Inﬂuenza virus (H9N1, H3N2, and H9N1) were heat inactivated
at 56 °C for 30 min. The viral plaque assay was performed to
conﬁrm the complete inactivation of the virus.RNA Isolation and QPCR
Total RNA from airway epithelial cells was isolated using the
RNeasy plus Mini kit (Qiagen, MD) according to the manufacturer's
instructions. cDNA was generated using the High capacity ABI-RT
PCR kit (Life Technologies, CA). Real time qPCR reactions were
carried out using the TaqMan FAST PCR reagent (Life Technologies)
and the ABI 7500 FAST real-time PCR cycler (Life Technologies).
TaqMan primers for ICAM-1, NF-ĸB and glyceraldehyde phosphate
dehydrogenase (GAPDH) were purchased from Life Technologies.
Differences in expression were determined using a ΔΔct method
and GAPDH was used for normalization.Inﬂuenza matrix gene expression was quantiﬁed and reported
as inﬂuenza copy number. QPCR was performed using the TaqMan
assay with matrix-speciﬁc primers, as reported earlier (Blachere
et al., 2011; Spackman et al., 2002). All primers and probes were
custom synthesized by Life Technologies. To determine the relative
matrix gene copy number from inﬂuenza virus strains, a standard
curve was generated from the cloned inﬂuenza H1N1 matrix gene
and analyzed concurrently with RT-PCR reactions (Othumpangat
et al., 2014).
PCR microarray
Total RNA from HBEpC exposed to H1N1, H3N2, or H9N1 was
puriﬁed using RNeasy kit as described earlier. PCR array for the
expression and identiﬁcation of different extracellular matrix and
adhesion molecules that are targeted by the inﬂuenza was studied
using the human Extracellular matrix and adhesion molecules RT2
Proﬁler™ array (Catalog # PAHS-008z, SABiosciences, Qiagen,
MD). Gene expression results were normalized to GAPDH, and
data analyzed using the supplier's online software (Qiagen) and
the ΔΔct method.
ICAM-1 knock-down by siRNA
The role of ICAM-1 during inﬂuenza infection was investigated
by silencing ICAM-1 gene expression in epithelial cells with ICAM-
1 speciﬁc siRNA. HBEpC were transfected with ICAM1 siRNA or a
scrambled oligonucleotide (SCR) (Dharmacon, Thermoscientiﬁc,
CA) using the lipid-based Lipofectamine 2000 reagent diluted in
Opti-MEM-I reduced serum medium (Life Technologies) according
to the supplier's protocol. Brieﬂy, HBEpC were grown to 80%
conﬂuence in 6-well plates and the transfection complexes were
made in Opti-MEM and directly applied to the cells to a ﬁnal
concentration of 25 or 50 nM. After 6–8 h of transfection, the
medium was replaced with fresh complete medium. After 24–36 h
transfected cells were exposed to inﬂuenza virus (1.0 MOI),
according to standard infection protocols. Following virus chal-
lenge, cells were collected by trypsinization and the resulting
pellet was used for RNA extraction or protein for Western blot
analysis.
ICAM-1 quantiﬁcation by ELISA
The changes in secreted ICAM-1 protein during inﬂuenza virus
infection were quantitated using a commercially available ELISA
kit (R&D systems, MN). HBEpC were grown to conﬂuence in 6-well
plates and infected with MOI of 1.0 H1N1 (WSN), H3N2, and H9N1
for 3 h. Supernatants were collected following infection and cen-
trifuged to remove cell debris. ELISA for ICAM-1 was completed
according to the manufacturer's instructions. The plates were read
using a multiwall plate reader (Bio-Tek Instruments Inc., VT) and
analyzed using the software of Gen5-2.0 (Bio-Tek).
Flow cytometry
HBEpC were grown to conﬂuence in 6-well plates and infected
with MOI of 1.0 of H1N1 (WSN), H3N2, and H9N1 for 3 h. Cells
were isolated by trypsinization and were stained for surface
detection of ICAM-1 protein using ICAM-1 speciﬁc antibody.
ICAM-1 (CD54) mouse monoclonal antibody and the matching
isotype control were purchased from (BD Biosciences, San Jose,
CA). Secondary ﬂuorescent antibody labeled with Alexa 555 was
from Life Technologies (Carlsbad, CA). Data were acquired and
analyzed using FACS LSRII (BD Biosciences).
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HBEpCs were grown on chamber slides overnight (Chamber
slide™, Lab-TekII, Thermo Fisher Scientiﬁc, Rochester, NY) or until
80–90% conﬂuence. Cells were then infected for 3 h with H1N1 or
H3N2 strains or an uninfected control. Subsequently, cells were
washed with PBS, and ﬁxed with 4% methanol-free formaldehyde
(Polysciences Inc., Warrington, PA). Immunoﬂuorescent staining
was done as described earlier (Othumpangat et al., 2013) and
stained with rabbit anti-ICAM1 antibody (Millipore, Billerica, MA)
for 1 h, followed by Alexa-488 conjugated anti-rabbit secondary
antibody and Phalloidin (Life Technologies). The slides were
mounted with DAPI-Prolong Gold anti-fade reagent (Life Tech-
nologies) and protected with cover slips. Photomicrographs were
made using a Zeiss LSM510 (Carl Zeiss, Obertochen, AG Germany)
confocal microscope.
Western immunoblotting
HBEpCs were mock infected or infected at an MOI of 1.0 with
H1N1 (WSN), H3N2 and H9N1 or the heat inactivated virus. Three
hours postinfection (p.i.), cells were lysed in 100 ml of radio-
immunoprecipitation assay (RIPA) buffer (Thermo Scientiﬁc, MA)
containing the protease inhibitor cocktail. Thirty micrograms of pro-
tein was solubilized in protein sample buffer and subjected to elec-
trophoresis on 10% or 4–20% precast gradient SDS-polyacrylamide
gels (SDS-PAGE, Bio-Rad, CA). Separated proteins were transferred to
a nitrocellulose membrane (Millipore, MA). Membranes were blocked
using Odyssey Blocking Buffer (LI-COR Biosciences, Lincoln, NE) for
1 h at room temperature and subjected to Western analysis with
rabbit polyclonal anti-ICAM-1 (CD54, BD Biosciences), mouse mono-
clonal anti NF-ĸBp65 (EMD Millipore, MA) and mouse monoclonal
anti-GAPDH (Abcam, MA). Appropriate mouse and rabbit IR Dye 680
or 800 secondary antibodies (LI-COR Biosciences) were used. Near-
infrared ﬂuorescence detection was performed on the Odyssey Ima-
ging System (LI-COR Biosciences, Lincoln, NE).
To understand whether the up-regulation of ICAM-1 mRNA
expression alters inﬂuenza infection efﬁciency, exogenous IL-1β
was added (50 or 100 ng/ml; R&D systems) to HBEpCs. The cells
were incubated for 2 h with IL-1β prior to virus challenge. Protein
was isolated from the treated cells and subjected to Western blot
analysis.
NF-ĸB reporter assay
NF-ĸB cignal reporter kit (Cignal™ Reporter Assay, SABios-
ciences, Qiagen, MD) was used to assess NF-ĸB activity in HBEpC.
The kit contains the NF-ĸB responsive luciferase construct which
encodes the ﬁreﬂy luciferase reporter gene under the control of a
minimal CMV promoter and tandem repeats of the NF-ĸB tran-
scriptional response element (TRE). Brieﬂy, cells (1104 cells/
well) were plated on a 96-well plate containing the transfection
agent (Lipofectamine 2000, Life Technologies), the NF-ĸB reporter,
and co-transfected with the siRNA for ICAM1 and the scrambled
siRNA (50 nM). After 16 h of transfection, the transfection media
was replaced with regular growth media and incubated for 16–
18 h. Subsequently, the cells were exposed to inﬂuenza virus H1N1
for 3 h. NF-ĸB activity was assessed using the luciferase assay
system (Dual-Glos Luciferase Assay, Promega, WI). Cells were
lysed with the passive lysis buffer (provided in the kit) before
luminescence was detected with a Glomaxs 96 well microplate
Luminometer (Promega). NF-ĸB activity was standardized to the
transfection of each cell by normalizing data to Renilla
luminescence.Statistical analysis
Analysis of variance (ANOVA) was used to analyze qPCR, and
reporter assay data. The post-hoc pairwise comparisons between
means were performed using the Holm–Sidak method with a p
value of o0.05 considered statistically signiﬁcant (Sigmaplot
version 12.5 for Windows, Systat Software, Chicago, IL).Acknowledgments
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